ÃâÒßѧÊÔÌâ
73/DOF Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
K|n%8hRy 1. Fas(CD95)/FasL
M1nH!A~o 2. common chain of cytokine receptor
U&F1}P$fb 3 . TCR/CD3 complex
u.\F
Na 4. negaive selection of thymocytes
^a>3U l{ 5. artificial active immune
_:N+mEF 6. anti-idiotypic
r'|V z*/h 7. IgSF
l]g
/rs 8. Integrin
Go^a~Sf$ 9. chemokine
m8j Q~OS 10. B7/CD28
a *hWODYn ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
dnwTD\), 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
E{wnhsl{ 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
Os90fR 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
s'7PHP)LOJ 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
.8GX8[t
ZXJ]== 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
_YK66cS3E/ µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
>P<8E2}* Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
u# TNW. 1. B7/CD28
icrcP ~$A 2. Th1 subset
5wE+p<-KX 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
?5IF;vk 4. antibody affinity maturation
\PzJ66DL! 5. AP-1
m{w'&\T 6. single chain variable fragment£¨ScFv£©
R9&3QRW| 7. NK cell receptor
=#Z+WD-E 8. Zinkernagel-Doherty phenomenon
m ?e::W 9. Ig fold
/ucS*m:<x 10. CD40/CD40L
/'l"Us},^! ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
'PqKb%B| 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
z 0}JiW R 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
KSYHG 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
T!jMh-8 Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
Y6E0-bL@Fe 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
Y2TXWl,Jk 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
1KadT7<0} 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
96d&vm~m1 Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
$vLGX>H £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
rU
|% Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
A7I{Le 1.Co-stimulators (or co-stimulating molecules)
[$D%]]/, 2.NK-kB
xdgbs-a) 3.Immunoglobulin superfamily
%D49A-R 4.antigen-presenting cell (APC)
J(Fk@{!F.* 5.death domain
{rzvZ0-j} 6.CCR and CXCR
H-qbgd6&>R 7.Lectin (or mitogen)
;3\'}2^|l 8.Clusters of differentiation, CD)
= G>Y9Sc 9.B7 family
9hei8L: 10.Cytotoxic T lymphocyte, CTL)
tI<6TE'!p# 11.IL-15 and IL-15 receptor (IL-15R)
2Mu3]2> 12.MHC restriction
pD]2.O 13.Affinity-chromatography
TPA*z9n+B 14.Cyctosprin A, CsA
tP89gN^PA| 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
XZ"oOE0= ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
lXRB"z 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
K_fJ{Vc>O 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
"8
?6;!, 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
{S`Rr/E|% Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
5&_R+g ÃâÒßѧרҵ£º
P! P` MX 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
j:$Z-s Ïû»¯ÄÚ¿Æ£º
]/|DCxQ 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
tILnD1q ѪҺ²¡Ñ§×¨Òµ£º
~FVbL-2 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
ZU`HaL$ Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
|M
EJ)LE7 (רҵ»ù´¡: ÃâÒßѧ)
?lm<)y?I7+ Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
?4t~z 1.f 1. ADCC(antibody dependent cell-mediated cytotoxicity)
Mo]iVj8~ 2. »·æß¾úËØ(cyclosporin)
$#_^uWN-M 3. KIR(killer cell inhibitory receptor)
OqX+R4S 4. HLDA(human leucocyte differentiation antigen)
u1|v3/Q- 5. Interleukin 18(IL-18)
I#xhmsF 6. ÕûºÏËØ(integrin)
3*R(&O6} 7. Fas/FasL
OA7=kH@3c 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
M#yUdl7d 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
[n +( 10. Th1/Th2
@"^(} 6 11. »ùÒòÒßÃç(DNAÒßÃç)
R!WeSgKCs 12. chemokines and chemokine receptor
M<@9di7c 13. ÃâÒßÄÍÊÜ
)EG-xo@X 14. ¹²´Ì¼¤·Ö×Ó
)' 2vUt`_7 15. ËÀÍö½á¹¹Óò(death domain)
+*RpOtss ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
%;` 3I$ 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
* =O@D2g0 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
Q?%v b £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
U4Pk^[,p1G £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
CjA}-ee £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
C%'eF` £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
q5w)i 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
Sq2yQSd Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
=`%%*
ÎÊ´ðÌâ(ÿÌâ25·Ö)
$w<~W1\: 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
p|w;StLy 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
fGLOXbsA 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
/XW,H0pR 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£